Time course of carcinoembryonic antigen after resection of lung cancer: a predictor of recurrence
- PMID: 12901802
- PMCID: PMC11160278
- DOI: 10.1111/j.1349-7006.2003.tb01512.x
Time course of carcinoembryonic antigen after resection of lung cancer: a predictor of recurrence
Abstract
We investigated whether the early postoperative time course of carcinoembryonic antigen (CEA) level after resection of lung cancer could be used to predict patients' prognosis. Fifty-three lung cancer patients were included in this study. Postoperative serum CEA levels were calculated by means of non-linear least-squares fitting to the equation C(t) = (C(0)-C(p))exp(-kt) + C(p), where C(t) is postoperative CEA level, t is days after surgery, C(0) is CEA level at postoperative time 0, C(p) is CEA level at plateau, and k is the rate constant of elimination. Postoperative CEA production (P(p)) was calculated as C(p) multiplied by k. C(p) and P(p) represent the numbers of residual tumor cells after surgery. More residual tumor cells yield higher values of C(p) and P(p), and result in earlier recurrence.
Results: Kinetic parameters could be obtained for 30 patients whose preoperative CEA levels were sufficiently elevated. Cutoff levels as predictors for recurrence were 1.1 ng/ml for C(p) and 0.9 ng/ml/day for P(p). The accuracy of prediction of recurrence using these cutoff levels was 79% with C(p) and 89% with P(p). A very poor prognosis was observed for patients with P(p) over 0.9 ng/ml/day.
Conclusion: Analysis of the time course of changes in CEA levels after resection of lung cancer appears to be useful for predicting patient prognosis. C(p) and P(p) are very precise predictors of recurrence.
Similar articles
-
Analysis of the early postoperative serum carcinoembryonic antigen time-course as a prognostic tool for bronchogenic carcinoma.Cancer. 1997 Apr 15;79(8):1533-40. doi: 10.1002/(sici)1097-0142(19970415)79:8<1533::aid-cncr14>3.0.co;2-z. Cancer. 1997. PMID: 9118035
-
Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.Ann Surg Oncol. 2008 Dec;15(12):3433-9. doi: 10.1245/s10434-008-0168-8. Epub 2008 Oct 10. Ann Surg Oncol. 2008. PMID: 18846401
-
Monitoring of Serum Carcinoembryonic Antigen Levels after Curative Resection of Colon Cancer: Cutoff Values Determined according to Preoperative Levels Enhance the Diagnostic Accuracy for Recurrence.Oncology. 2017;92(5):276-282. doi: 10.1159/000456075. Epub 2017 Feb 9. Oncology. 2017. PMID: 28178692 Free PMC article.
-
A case of serum CEA disappearance curve after resection of breast carcinoma.Breast Cancer. 2004;11(2):203-5. doi: 10.1007/BF02968302. Breast Cancer. 2004. PMID: 15550868
-
Carcinoembryonic antigen (CEA) as tumor marker in lung cancer.Lung Cancer. 2012 May;76(2):138-43. doi: 10.1016/j.lungcan.2011.11.012. Epub 2011 Dec 6. Lung Cancer. 2012. PMID: 22153832 Review.
Cited by
-
Large-cell neuroendocrine carcinoma without immunohistological positivity or serum elevation of CEA until relapse.Gen Thorac Cardiovasc Surg. 2008 Nov;56(11):547-50. doi: 10.1007/s11748-008-0297-9. Epub 2008 Nov 12. Gen Thorac Cardiovasc Surg. 2008. PMID: 19002754
-
Prognostic significance of CEA reduction rate in patients with abnormally high preoperative CEA levels who underwent surgery for lung cancer.J Cardiothorac Surg. 2024 Dec 20;19(1):662. doi: 10.1186/s13019-024-03166-z. J Cardiothorac Surg. 2024. PMID: 39702201 Free PMC article.
-
Prognostic significance of postoperative serum carcinoembryonic antigen levels in patients with completely resected pathological-stage I non-small cell lung cancer.J Cardiothorac Surg. 2013 Apr 22;8:106. doi: 10.1186/1749-8090-8-106. J Cardiothorac Surg. 2013. PMID: 23607757 Free PMC article.
-
Annual periodic increases in serum carcinoembryonic antigen concurrent with ground-glass opacity in the lung: report of a case.Surg Today. 2005;35(10):883-5. doi: 10.1007/s00595-005-3010-y. Surg Today. 2005. PMID: 16175472
References
-
- Semjonow A, Hamm M, Rathert P. Elimination kinetics of prostate‐specific antigen serum and urine. Int J Biol Markers 1994; 9: 15–20. - PubMed
-
- Willemse PHB, Aalders JG, de Bruyn HWA, Mulder NH, Sleijfer DTh, de Vries EGE. CA‐125 in ovarian cancer: relation between half‐life, doubling time and survival. Eur J Cancer 1991; 27: 993–5. - PubMed
-
- Lange PH, Vogelzang NJ, Goldman A, Kennedy BJ, Fraley EE. Marker half‐life analysis as a prognostic tool in testicular cancer. J Urol 1982; 128: 708–11. - PubMed
-
- Ueda H, Kusano T, Iwasaki A, Inutsuka S. Postoperative change of serum carcinoembryonic antigen in bronchogenic carcinoma. Med Bull Fukuoka Univ 1991; 18: 187–91.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous